Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model

Conclusions: These results provide the first evidence of the potential utility of lixivaptan for the treatment of ADPKD.Am J Nephrol 2019;49:487 –493
Source: American Journal of Nephrology - Category: Neurology Source Type: research